User login
A supplement to Family Practice News.
Letter From Guest Editor
Larry Culpepper, MD, MPH
Chief of Family Medicine
Boston Medical Center
Professor and Chairman of Family Medicine
Boston University School of Medicine
Boston, Mass.
Special Populations in Depression: Applying Cultural Flexibility to Depression in Minority Populations
William B. Lawson, MD, PhD, DFAPA
Professor and Chair
Department of Psychiatry and Behavioral Sciences
Director, Mood Research Program
Howard University College of Medicine and Hospital
Washington, D.C.
Dr Lawson has disclosed that he has received clinical grants from AstraZeneca, the National Institute of Mental Health, and Pfizer Inc., and is a consultant to AstraZeneca and Pfizer.
Resources in the Spotlight
Practical Bits: Quick and Practical Diagnostic Tools
Case File on Seasonal Affective Disorder
David L. Dunner, MD, FACPsychDirector, Center for Anxiety and Depression
Professor Emeritus, Department of Psychiatry and Behavioral Sciences
University of Washington School of Medicine
Seattle, Wash.
Dr Dunner has disclosed that he has received grant support from, is on the advisory board of, and/or on the speaker's bureau of Bristol-Myers Squibb Company, Corcept Therapeutics, Cyberonics, Inc., Cypress Bioscience Inc., Eli Lilly and Company, Forest Laboratories, Inc., GlaxoSmithKline, Healthcare Technology Systems, Janssen, L.P., Novartis Pharmaceuticals Corporation, Organon, Otsuka America Pharmaceuticals, Pfizer Inc., Roche Diagnostics, Shire Pharmaceuticals Group plc, Somerset Pharmaceuticals, Inc., and Wyeth Pharmaceuticals.
Case File on Depression in Minorities
Peggy L. Johnson, MD
Assistant Professor
Vice Chair for Clinical Services
Department of Psychiatry
Boston University School of Medicine
Boston, Mass.
Dr Johnson has nothing to disclose.
Clinical Approaches to Recognizing and Managing Bipolar Disorder
Andrew J. Cutler, MD
Courtesy Assistant Professor, Department of Psychiatry
University of Florida
President and Medical Director
Florida Clinical Research Center, LLC
Maitland, Fla.
Dr Cutler has disclosed that he has received research grants from Abbott Laboratories Pharmaceutical Product Division, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Cephalon, Inc., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly and Company, Forest Laboratories, Inc., GlaxoSmithKline, Janssen, L.P., JDS Pharmaceuticals LLC, Johnson & Johnson PRD, Memory Pharmaceuticals, Novartis Pharmaceuticals Corporation, Organon, Otsuka America Pharmaceuticals, Pfizer, Sanofi, Sepracor Inc., Shire Pharmaceuticals Group plc, Solvay Pharmaceuticals, Vanda Pharmaceuticals, and Wyeth Pharmaceuticals. He is a consultant and on the speaker's bureau for Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline,Janssen, Otsuka, Pfizer, Sepracor, Shire, and Vanda. He is also a consultant to Supernus Pharmaceuticals, Inc.
Adults With ADHD Need to Know Treatment Options
Carl C. Bell, MD
Chief, Executive Officer and President
Community Mental Health Council, Inc.
Director, Public and Community Psychiatry
University of Illinois, Chicago, Ill.
Copyright © 2007 Elsevier Inc.
A supplement to Family Practice News.
Letter From Guest Editor
Larry Culpepper, MD, MPH
Chief of Family Medicine
Boston Medical Center
Professor and Chairman of Family Medicine
Boston University School of Medicine
Boston, Mass.
Special Populations in Depression: Applying Cultural Flexibility to Depression in Minority Populations
William B. Lawson, MD, PhD, DFAPA
Professor and Chair
Department of Psychiatry and Behavioral Sciences
Director, Mood Research Program
Howard University College of Medicine and Hospital
Washington, D.C.
Dr Lawson has disclosed that he has received clinical grants from AstraZeneca, the National Institute of Mental Health, and Pfizer Inc., and is a consultant to AstraZeneca and Pfizer.
Resources in the Spotlight
Practical Bits: Quick and Practical Diagnostic Tools
Case File on Seasonal Affective Disorder
David L. Dunner, MD, FACPsychDirector, Center for Anxiety and Depression
Professor Emeritus, Department of Psychiatry and Behavioral Sciences
University of Washington School of Medicine
Seattle, Wash.
Dr Dunner has disclosed that he has received grant support from, is on the advisory board of, and/or on the speaker's bureau of Bristol-Myers Squibb Company, Corcept Therapeutics, Cyberonics, Inc., Cypress Bioscience Inc., Eli Lilly and Company, Forest Laboratories, Inc., GlaxoSmithKline, Healthcare Technology Systems, Janssen, L.P., Novartis Pharmaceuticals Corporation, Organon, Otsuka America Pharmaceuticals, Pfizer Inc., Roche Diagnostics, Shire Pharmaceuticals Group plc, Somerset Pharmaceuticals, Inc., and Wyeth Pharmaceuticals.
Case File on Depression in Minorities
Peggy L. Johnson, MD
Assistant Professor
Vice Chair for Clinical Services
Department of Psychiatry
Boston University School of Medicine
Boston, Mass.
Dr Johnson has nothing to disclose.
Clinical Approaches to Recognizing and Managing Bipolar Disorder
Andrew J. Cutler, MD
Courtesy Assistant Professor, Department of Psychiatry
University of Florida
President and Medical Director
Florida Clinical Research Center, LLC
Maitland, Fla.
Dr Cutler has disclosed that he has received research grants from Abbott Laboratories Pharmaceutical Product Division, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Cephalon, Inc., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly and Company, Forest Laboratories, Inc., GlaxoSmithKline, Janssen, L.P., JDS Pharmaceuticals LLC, Johnson & Johnson PRD, Memory Pharmaceuticals, Novartis Pharmaceuticals Corporation, Organon, Otsuka America Pharmaceuticals, Pfizer, Sanofi, Sepracor Inc., Shire Pharmaceuticals Group plc, Solvay Pharmaceuticals, Vanda Pharmaceuticals, and Wyeth Pharmaceuticals. He is a consultant and on the speaker's bureau for Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline,Janssen, Otsuka, Pfizer, Sepracor, Shire, and Vanda. He is also a consultant to Supernus Pharmaceuticals, Inc.
Adults With ADHD Need to Know Treatment Options
Carl C. Bell, MD
Chief, Executive Officer and President
Community Mental Health Council, Inc.
Director, Public and Community Psychiatry
University of Illinois, Chicago, Ill.
Copyright © 2007 Elsevier Inc.
A supplement to Family Practice News.
Letter From Guest Editor
Larry Culpepper, MD, MPH
Chief of Family Medicine
Boston Medical Center
Professor and Chairman of Family Medicine
Boston University School of Medicine
Boston, Mass.
Special Populations in Depression: Applying Cultural Flexibility to Depression in Minority Populations
William B. Lawson, MD, PhD, DFAPA
Professor and Chair
Department of Psychiatry and Behavioral Sciences
Director, Mood Research Program
Howard University College of Medicine and Hospital
Washington, D.C.
Dr Lawson has disclosed that he has received clinical grants from AstraZeneca, the National Institute of Mental Health, and Pfizer Inc., and is a consultant to AstraZeneca and Pfizer.
Resources in the Spotlight
Practical Bits: Quick and Practical Diagnostic Tools
Case File on Seasonal Affective Disorder
David L. Dunner, MD, FACPsychDirector, Center for Anxiety and Depression
Professor Emeritus, Department of Psychiatry and Behavioral Sciences
University of Washington School of Medicine
Seattle, Wash.
Dr Dunner has disclosed that he has received grant support from, is on the advisory board of, and/or on the speaker's bureau of Bristol-Myers Squibb Company, Corcept Therapeutics, Cyberonics, Inc., Cypress Bioscience Inc., Eli Lilly and Company, Forest Laboratories, Inc., GlaxoSmithKline, Healthcare Technology Systems, Janssen, L.P., Novartis Pharmaceuticals Corporation, Organon, Otsuka America Pharmaceuticals, Pfizer Inc., Roche Diagnostics, Shire Pharmaceuticals Group plc, Somerset Pharmaceuticals, Inc., and Wyeth Pharmaceuticals.
Case File on Depression in Minorities
Peggy L. Johnson, MD
Assistant Professor
Vice Chair for Clinical Services
Department of Psychiatry
Boston University School of Medicine
Boston, Mass.
Dr Johnson has nothing to disclose.
Clinical Approaches to Recognizing and Managing Bipolar Disorder
Andrew J. Cutler, MD
Courtesy Assistant Professor, Department of Psychiatry
University of Florida
President and Medical Director
Florida Clinical Research Center, LLC
Maitland, Fla.
Dr Cutler has disclosed that he has received research grants from Abbott Laboratories Pharmaceutical Product Division, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Cephalon, Inc., Dainippon Sumitomo Pharma Co., Ltd., Eli Lilly and Company, Forest Laboratories, Inc., GlaxoSmithKline, Janssen, L.P., JDS Pharmaceuticals LLC, Johnson & Johnson PRD, Memory Pharmaceuticals, Novartis Pharmaceuticals Corporation, Organon, Otsuka America Pharmaceuticals, Pfizer, Sanofi, Sepracor Inc., Shire Pharmaceuticals Group plc, Solvay Pharmaceuticals, Vanda Pharmaceuticals, and Wyeth Pharmaceuticals. He is a consultant and on the speaker's bureau for Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline,Janssen, Otsuka, Pfizer, Sepracor, Shire, and Vanda. He is also a consultant to Supernus Pharmaceuticals, Inc.
Adults With ADHD Need to Know Treatment Options
Carl C. Bell, MD
Chief, Executive Officer and President
Community Mental Health Council, Inc.
Director, Public and Community Psychiatry
University of Illinois, Chicago, Ill.
Copyright © 2007 Elsevier Inc.
